Across each stage of CKD, this ratio demonstrated a stepwise increase indicative of an incremental loss of HSD11B2 activity and a reduction in downstream active 11-oxygenated androgens with progression of renal failure (Fig. 3E). Here, HSD11B2 is linked to chronic kidney disease.